Anthony Gilbert

Anthony Gilbert

Auto-generated profile, based on publicly available information

Anthony Gilbert

Retroscreen Virology, London, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TWTom M Wilkinson
Tom M Wilkinson
CLChris K F Li
Chris K F Li
CCCecilia S C Chui
Cecilia S C Chui
AHArthur K Y Huang
Arthur K Y Huang
MPMolly Perkins
Molly Perkins
XXXiao-Ning Xu
Xiao-Ning Xu

9 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CWChristopher Wildrick Woods
Christopher Wildrick Woods
MMMicah T. McClain
Micah T. McClain
MCMinhua Chen
Minhua Chen
AZAimee K. Zaas
Aimee K. Zaas
BNBradly P. Nicholson
Bradly P. Nicholson
GGGeoffrey S. Ginsburg
Geoffrey S. Ginsburg
There is great potential for host-based gene expression analysis to impact the early diagnosis of infectious diseases. In particular, the influenza pandemic of 2009 highlighted the challenges and limitations of traditional pathogen-based testing for suspected upper respiratory viral infection. We inoculated human volunteers with either influenza A (A/Brisbane/59/2007 (H1N1) or A/Wisconsin/67/2005 (H3N2)), and assayed the peripheral blood transcriptome every 8 hours for 7 days. Of 41 inoculated volunteers, 18 (44%) developed symptomatic infection. Using unbiased sparse latent factor regression analysis, we generated a gene signature (or factor) for symptomatic influenza capable of detecting 94% of infected cases. This gene signature is detectable as early as 29 hours post-exposure and achieves maximal accuracy on average 43 hours (p = 0.003, H1N1) and 38 hours (p-value = 0.005, H3N2) before peak clinical symptoms. In order to test the relevance of these findings in naturally acquired disease, a composite influenza A signature built from these challenge studies was applied to Emergency Department patients where it discriminates between swine-origin influenza A/H1N1 (2009) infected and non-infected individuals with 92% accuracy. The host genomic response to Influenza infection is robust and may provide the means for detection before typical clinical symptoms are apparent.

15 December 2016 in Journal of Virology
Verified
Journal Article
Open access
PDF file
ALAshley Sobel Leonard
Ashley Sobel Leonard
MMMicah T. McClain
Micah T. McClain
GSGavin J. D. Smith
Gavin J. D. Smith
DWDavid E. Wentworth
David E. Wentworth
RHRebecca A. Halpin
Rebecca A. Halpin
KKKatia Koelle
Katia Koelle
Knowledge of influenza virus evolution at the point of transmission and at the intrahost level remains limited, particularly for human hosts. Here, we analyze a unique viral data set of next-generation sequencing (NGS) samples generated from a human influenza challenge study wherein 17 healthy subjects were inoculated with cell- and egg-passaged virus. Nasal wash samples collected from 7 of these subjects were successfully deep sequenced. From these, we characterized changes in the subjects' viral populations during infection and identified differences between the virus in these samples and the viral stock used to inoculate the subjects. We first calculated pairwise genetic distances between the subjects' nasal wash samples, the viral stock, and the influenza virus A/Wisconsin/67/2005 (H3N2) reference strain used to generate the stock virus. These distances revealed that considerable viral evolution occurred at various points in the human challenge study. Further quantitative analyses indicated that (i) the viral stock contained genetic variants that originated and likely were selected for during the passaging process, (ii) direct intranasal inoculation with the viral stock resulted in a selective bottleneck that reduced nonsynonymous genetic diversity in the viral hemagglutinin and nucleoprotein, and (iii) intrahost viral evolution continued over the course of infection. These intrahost evolutionary dynamics were dominated by purifying selection. Our findings indicate that rapid viral evolution can occur during acute influenza infection in otherwise healthy human hosts when the founding population size of the virus is large, as is the case with direct intranasal inoculation. IMPORTANCE Influenza viruses circulating among humans are known to rapidly evolve over time. However, little is known about how influenza virus evolves across single transmission events and over the course of a single infection. To address these issues, we analyze influenza virus sequences from a human challenge experiment that initiated infection with a cell- and egg-passaged viral stock, which appeared to have adapted during its preparation. We find that the subjects' viral populations differ genetically from the viral stock, with subjects' viral populations having lower representation of the amino-acid-changing variants that arose during viral preparation. We also find that most of the viral evolution occurring over single infections is characterized by further decreases in the frequencies of these amino-acid-changing variants and that only limited intrahost genetic diversification through new mutations is apparent. Our findings indicate that influenza virus populations can undergo rapid genetic changes during acute human infections.

1 December 2013 in Journal of Clinical Virology
Verified
Journal Article
Closed access
MMMicah T. McClain
Micah T. McClain
LPLawrence P. Park
Lawrence P. Park
BNBradly Nicholson
Bradly Nicholson
TVTimothy Veldman
Timothy Veldman
AZAimee K. Zaas
Aimee K. Zaas
CWChristopher W. Woods
Christopher W. Woods

10 January 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KHKuan-Ying Arthur Huang
Kuan-Ying Arthur Huang
CLChris Ka-Fai Li
Chris Ka-Fai Li
ECElizabeth Clutterbuck
Elizabeth Clutterbuck
CCCecilia Chui
Cecilia Chui
TWTom Wilkinson
Tom Wilkinson
XXXiao-Ning Xu
Xiao-Ning Xu
Background. Antibodies play a major role in the protection against influenza virus in human. However, the antibody level is usually short-lived and the cellular mechanisms underlying influenza virus–specific antibody response to acute infection remain unclear. Methods. We studied the kinetics and magnitude of influenza virus–specific B-cell and serum antibody responses in relation to virus replication during the course of influenza infection in healthy adult volunteers who were previously seronegative and experimentally infected with seasonal influenza H1N1 A/Brisbane/59/07 virus. Results. Our data demonstrated a robust expansion of the virus-specific antibody-secreting cells (ASCs) and memory B cells in the peripheral blood, which correlated with both the throat viral load and the duration of viral shedding. The ASC response was obviously detected on day 7 post-infection when the virus was completely cleared from nasal samples, and serum hemagglutination-inhibition antibodies were still undetectable. On day 28 postinfection, influenza virus-specific B cells were further identified from the circulating compartment of isotype-switched B cells. Conclusions. Virus-specific ASCs could be the earliest marker of B-cell response to a new flu virus infection, such as H7N9 in humans.

30 November 2011 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
BKBen Killingley
Ben Killingley
JEJoanne E. Enstone
Joanne E. Enstone
JGJane Greatorex
Jane Greatorex
AGAnthony S. Gilbert
Anthony S. Gilbert
RLRob Lambkin-Williams
Rob Lambkin-Williams
JVJonathan S. Nguyen Van-Tam
Jonathan S. Nguyen Van-Tam
Background. Influenza transmission in humans remains poorly understood. In particular, the relative contribution of contact, large droplet, and aerosol transmission is unknown. The aims of this proof-of-concept study were to determine whether an experimentally induced influenza infection is transmissible between humans and whether this would form a viable platform for future studies. Methods. In a quarantine facility, healthy volunteers (“donors”) were inoculated with A/Wisconsin/67/2005 (H3N2) influenza virus via intranasal drops. On study days 2 and 3 “recipient” volunteers were exposed to donors under close living conditions. Volunteers socialized for 30 hours during a 2-day period. Infection was confirmed by ≥1 positive results from polymerase chain reaction, virus culture, or serology. Results. After inoculation, 4 of 9 donors developed symptoms consistent an influenza-like illness (ILI) and 7 of 9 were proven to be influenza-infected. After exposure, 4 of 15 recipients developed symptoms of ILI and 3 of 15 were proven to be infected. Serum collected within 2 days of study initiation indicated that 1 donor and 3 recipients were seropositive at study initiation. After adjustment for preexposure immunity, the overall secondary attack rate was 25% (3 of 12). Conclusions. Experimental human exposure studies offer an attractive potential method for answering outstanding questions related to influenza transmission and the evaluation of interventions to reduce it.